Clinical Trials Browser

Has results × Carcinoma, Neuroendocrine × Bevacizumab × Clear all

NCT01121939 2016-02-05

Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers

Phase 2 Completed

43 enrolled 9 charts

Carcinoma, Neuroendocrine

NCT00607113 2013-07-18

Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine Carcinoma

Phase 2 Completed

41 enrolled 6 charts

Carcinoma, Neuroendocrine